Trials / Enrolling By Invitation
Enrolling By InvitationNCT07216144
Centralized Lung Cancer Screening Engagement in At-Risk Populations
Centralized Lung Cancer Screening Engagement in At-Risk Populations (CLEAR)
- Status
- Enrolling By Invitation
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 2,000 (estimated)
- Sponsor
- Weill Medical College of Cornell University · Academic / Other
- Sex
- All
- Age
- 50 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This study will assess the impact of centralized outreach on lung cancer screening completion among individuals served by Federally Qualified Health Centers.
Detailed description
This will be a two-arm, parallel, pragmatic randomized controlled trial (RCT) to evaluate the effectiveness of a centralized patient outreach strategy in increasing lung cancer screening (LCS) completion among populations served by Federally Qualified Health Centers (FQHCs). This study will randomize individuals potentially eligible for LCS (50-80 years, current or past smokers) to receive centralized patient outreach in addition to usual care (outreach arm) and usual care alone (usual care arm). Individuals assigned to the outreach arm will receive centralized patient outreach from the Lung screening team through a letter followed by up to three attempts of telephone contact. Individuals assigned to the usual care arm will not receive any contact during the study period and the referral for LCS will be made at the treating physician's discretion.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Centralized patient outreach for lung cancer screening | Centralized patient outreach for lung cancer screening will be conducted by the lung screening team and will consist of a letter followed by telephone contact. One week following the mail invitation, a senior patient coordinator (SPC) will make telephone contact with individuals to pre-screen eligibility determination based on pack-year smoking history. Up to three telephone contact attempts will be made within two weeks. |
Timeline
- Start date
- 2025-10-15
- Primary completion
- 2027-02-01
- Completion
- 2027-08-01
- First posted
- 2025-10-14
- Last updated
- 2025-12-10
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT07216144. Inclusion in this directory is not an endorsement.